Competition

  • April 21, 2026

    Students Want MoloLamken As New Lead For Aid-Fixing Case

    Students in an antitrust case against Brown University, the University of Pennsylvania and other elite schools have asked an Illinois federal judge to appoint trial lawyer Steven F. Molo and his firm MoloLamken LLP as lead counsel, touting his courtroom experience and the firm's track record in high-stakes complex litigation.

  • April 21, 2026

    Joe Gibbs Racing's Fast-Track Trial Is 'Unrealistic,' Court Told

    Joe Gibbs Racing LLC's bid to set a November trial date in a trade secrets suit against former competition director Chris Gabehart and rival team Spire Motorsports is "aggressive and unrealistic," Gabehart has argued in asking to instead push the trial to May 2027.

  • April 21, 2026

    Former Federal Attys Join Kelley Drye In New York, LA

    Two former federal prosecutors have returned to private practice and recently joined Kelley Drye & Warren LLP's New York and Los Angeles offices.

  • April 21, 2026

    Live Nation Fails In Bid For Quick Nix Of Antitrust Damages

    A New York federal court has refused to rule immediately on Live Nation's bid to strike expert testimony and set aside the damages awarded to state enforcers in the antitrust case accusing the company of monopolizing the live entertainment industry.

  • April 20, 2026

    Calif. AG Says Amazon Pressured Major Brands To Fix Prices

    Amazon bullied major brands like Levi Strauss & Co. and Hanesbrands Inc. to pressure Walmart, Target Corp. and other competing retailers to increase their prices on certain products to match Amazon's prices and ensure it can maintain its profit margins, according to new details unsealed Monday in California's price-fixing suit against the e-commerce giant.

  • April 20, 2026

    Live Nation To Pay $9.9M To Ditch DC AG Ticket Pricing Probe

    Live Nation will pay $9.9 million to escape a Washington, D.C., probe accusing it of deploying deceptive ticketing practices over the last decade, just days after a federal jury found that the company and its subsidiary Ticketmaster monopolized ticketing services for major concert venues.

  • April 20, 2026

    Reddit Defends Data-Scraping Claims Against Perplexity

    Reddit Inc. is defending its case accusing Perplexity AI Inc. and three data-scraping companies of circumventing security measures to access copyrighted content in order to train the artificial intelligence startup's "answer engine."

  • April 20, 2026

    PBMs Fail To Freeze Discovery In Mich.'s Drug-Pricing Case

    A pending motion to dismiss the Michigan attorney general's drug-pricing case against multiple pharmacy benefit managers does not preclude the PBMs from handing over agreements between PBMs and pharmacies to the state, a federal judge said in a motion hearing Monday.

  • April 20, 2026

    High Court SEC Case Threatens FERC Fraud Clawbacks

    Federal Energy Regulatory Commission efforts to claw back unjust profits from market frauds, a linchpin of the agency's enforcement work, face an uncertain future as the U.S. Supreme Court considers a challenge to the U.S. Securities and Exchange Commission's disgorgement powers.

  • April 20, 2026

    Live Nation Wants Expert, Damages Cut After Antitrust Verdict

    Live Nation is asking a New York federal court to strike the testimony of a key expert witness for the states and to wipe the damages awarded by the jury based on her work, in the antitrust case accusing the company of monopolizing the live entertainment industry.

  • April 20, 2026

    Kawasaki Asks To Double $48M Patent Win In Calif.

    Kawasaki has urged a California federal court to double the $48 million jury award it won last month in a patent infringement suit against Japanese technology company Rorze Corp., while Rorze is asking for a new trial.

  • April 20, 2026

    White & Case Partner Moves To A&O Shearman In DC

    Allen Overy Shearman Sterling has hired a career White & Case LLP partner in Washington, D.C., who had spent the past 13 years there working with antitrust and other matters, the firm announced Monday.

  • April 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.

  • April 20, 2026

    Justices Won't Review Vegas Hotel Algorithmic Pricing Suit

    The U.S. Supreme Court on Monday rejected a petition seeking to revive a proposed class action accusing casino-hotel operators on the Las Vegas Strip of using software from Cendyn Group to illegally inflate room rates.

  • April 20, 2026

    Justices Won't Review Class Cert. In $12B VRDO Suit

    The U.S. Supreme Court on Monday declined to review a Second Circuit decision upholding class certification in a $12 billion municipal-bond antitrust lawsuit after a group of major banks argued the district court erred in not resolving an expert witness evidence dispute before granting certification.

  • April 17, 2026

    Nexstar-Tegna Deal Blocked Amid DirecTV, AGs' Challenge

    A California federal judge on Friday issued a preliminary injunction barring, for now, the $6.2 billion merger of broadcast giants Nexstar and Tegna, ruling that state attorneys general and DirecTV are likely to prevail in proving that the deal is anticompetitive and will harm consumers as well as distributors.

  • April 17, 2026

    Bayer Loses Bid To Block J&J's Cancer Drug Survival Claims

    A Manhattan federal judge Friday refused to block Johnson & Johnson from advertising its prostate cancer drug as having a lower risk of death compared with Bayer's medication, saying Bayer has not shown it is likely to succeed on its claims that its rival's advertising campaign is false or misleading.

  • April 17, 2026

    Starbucks Wins 5th Circ. Bid To Scrap NLRB Subpoena Order

    The Fifth Circuit on Friday vacated a National Labor Relations Board order that dinged Starbucks for sending overbroad subpoenas to pro-union employees, saying in a published opinion that the board applied the wrong legal standard for determining whether the coffeehouse chain committed an unfair labor practice.

  • April 17, 2026

    'Constantly Shifting': Judge Rips Musk, OpenAI As Trial Nears

    A California federal judge Friday appeared frustrated with Elon Musk and OpenAI ahead of trial over Musk's challenge to OpenAI's conversion to a for-profit entity, criticizing the parties' "constantly shifting" positions and doubting whether she has the authority to grant the relief Musk requested.

  • April 17, 2026

    American Airlines Shuts Down United Merger Rumors

    American Airlines on Friday shut down speculation of a potential combination with United Airlines, saying it's not currently engaged in any merger talks with the Chicago-based carrier.

  • April 17, 2026

    DOJ's NFL Probe May Reshape Sports Broadcasting Law

    Though antitrust charges are in play in the U.S. Department of Justice's investigation into the NFL's deals with services like Amazon Prime and Netflix, experts say they don't see a strong federal case against the league's broadcasting practices, as focus may shift to updating a decades-old law governing how sports leagues negotiate television deals.

  • April 17, 2026

    Denver Food Truck Biz Says Rival Stole Secrets Via Sham Deal

    A Denver food truck business has claimed its would-be partners stole its operational playbook and then threatened its owner and employees, according to a lawsuit filed in Colorado state court.

  • April 17, 2026

    Denver Bookshop Says 'Book Society' Can't Be A Trademark

    A Denver independent bookstore asked a Colorado federal judge Friday to declare it is not infringing upon a California book and wine lounge or engaging in unfair competition by using "book society" in its name.

  • April 17, 2026

    Bill Floated To Nix Medical Residency Antitrust Exemption

    U.S. Sen. Mike Lee, R-Utah, has introduced legislation to repeal an antitrust exemption given to the medical residency matching program by Congress two decades ago, over concerns about wages and a bottleneck of medical school graduates.

  • April 17, 2026

    Life Sciences Firm Says Ex-VP Took Trade Secrets To Rival

    A Massachusetts life sciences startup says a former vice president who left the company last fall, purportedly to care for his ill wife, instead took trade secrets with him to a new job at a California rival.

Expert Analysis

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • 4 Lessons From FTC's Successful Bid To Block Edwards Deal

    Author Photo

    The Federal Trade Commission's recent victory in blocking Edwards Lifesciences' acquisition of JenaValve offers key insights for deals in life sciences and beyond, including considerations around nonprice dimensions and clear skies provisions, say attorneys at Orrick.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

  • FTC Focus: Testing Joint Enforcement Over Loyalty Programs

    Author Photo

    The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.

  • NYC Bar Opinion Warns Attys On Use Of AI Recording Tools

    Author Photo

    Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.

  • Ruling Helps Clarify FERC's Post-Jarkesy Enforcement Power

    Author Photo

    A North Carolina federal court's recent ruling in American Efficient v. Federal Energy Regulatory Commission may be a step in providing clarity on FERC's enforcement authority under the Federal Power Act in the wake of the U.S. Supreme Court's 2024 decision in U.S. Securities and Exchange Commission v. Jarkesy, say attorneys at Sidley.

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Aerospace And Defense Law: Trends To Follow In 2026

    Author Photo

    Some of the key 2026 developments to watch in aerospace and defense contracting law stem from provisions of this year's National Defense Authorization Act, a push to reform procurement, executive orders that announced Trump administration priorities, the upcoming Artemis space mission and continuing efforts to deploy artificial intelligence, say attorneys at Thompson Hine.

  • Aviation Watch: Busy Skies, Tough Market For Airlines In 2026

    Author Photo

    After a turbulent year in the U.S. commercial aviation sector, demand for air travel and premium service shows no signs of slackening in 2026, with airlines facing the need to compete in a saturated market, while seeking opportunities for consolidation and pursuing other avenues to profitability, says Alan Hoffman, a retired attorney and aviation expert.

  • Viewing The Merger Landscape Through An HPE-Juniper Lens

    Author Photo

    If considerations beyond antitrust law were taken into account to determine whether Section 7 of the Clayton Act was violated in the Hewlett Packard Enterprise-Juniper Networks deal, then legal practitioners advocating deal clearance may now have to argue that deals should be justified by considerations not set forth in the merger guidelines, says Matthew Cantor of Shinder Cantor.

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Navigating Trade Secret Exceptions In Noncompete Bans

    Author Photo

    Recent and ongoing developments in the noncompete landscape, including a potential decision from the Tenth Circuit in Edwards Lifesciences v. Thompson, could offer tools for employers to bring noncompete agreements within trade secret exceptions amid an era of heightened employee mobility, say attorneys at Sullivan & Cromwell.

  • Series

    Playing Tennis Makes Me A Better Lawyer

    Author Photo

    An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.